> Merkliste Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp: E-Artikel Titel: 5-ALA fluorescence in a WHO grade I papillary glioneuronal tumour: a case report Beteiligte: Lavrador, José Pedro; Kandeel, Hussein Shaaban; Kalb, Alison; Reisz, Zita; Al-Sarraj, Safa; Gullan, Richard; Ashkan, Keyoumars; Vergani, Francesco; Bhangoo, Ranjeev Erschienen: Springer Science and Business Media LLC, 2020 Erschienen in: Acta Neurochirurgica Sprache: Englisch DOI: 10.1007/s00701-020-04223-x ISSN: 0001-6268; 0942-0940 Entstehung: Anmerkungen: Beschreibung: <jats:title>Abstract</jats:title><jats:p>5-ALA is proven to be effective in high-grade glioma operative resection. The use of 5-ALA in WHO grade I lesions is still controversial. A 49-year-old lady was diagnosed in 2004 with a left temporal lobe lesion as an incidental finding; she was followed up clinically and radiologically. In 2016, the lesion showed contrast enhancement and she was offered surgical resection but given she is asymptomatic, she refused. In 2018, the lesion showed signs of transformation with ring contrast enhancement, increased vasogenic oedema and perfusion; the patient accepted surgery at that point. She had preoperative mapping by navigated transcranial magnetic stimulation and she had operative resection with 5-ALA. The tumour was bright fluorescent under Blue 400 filter—Zeiss Pentero 900©(Carl Zeiss Meditec)—and both bright fluorescence and pale fluorescence were resected. Postoperative MRI showed complete resection and histopathology revealed WHO grade I papillary glioneuronal tumour, negative for BRAF V600 mutation. WHO grade I papillary glioneuronal tumour may present as 5-ALA fluorescent lesions. From a clinical perspective, 5-ALA can be used to achieve complete resections in these lesions which, in most cases, can be curative.</jats:p>